Cardinal Health (NYSE:CAH) has made several significant moves recently, majorly focusing on strengthening its financial position and market presence. This includes the announcement of an increase in its dividend to $0.5056, despite its stock underperforming in comparison to competitors on certain days. Certain assets, such as those held by American Trust and Raleigh Capital Management Inc., plan to increase their position in Cardinal Health. Moreover, the company's commitment to delivering strong value and investor returns is evident with a report suggesting a stellar 157% return over the last five years. In another significant development, the company reportedly plans to acquire
Specialty Networks and its
PPS Analytics platform, positioning themselves as a technology enabled multispecialty service provider. However, it is not all smooth sailing, as the company also received a warning letter from
US FDA for marketing unapproved devices and announced a non-renewal of its contract with OptumRx. Amidst this turbulence, Cardinal Health reaffirmed its FY24 non-GAAP EPS Guidance and long-term targets and received a boost in positions by institutional ownership.
Cardinal Health CAH News Analytics from Tue, 15 Aug 2023 07:00:00 GMT to Sun, 16 Jun 2024 13:30:39 GMT -
Rating 2
- Innovation 4
- Information 7
- Rumor -6
